Stockscreener 앱 받기
25.23
5.85%
-1.50
전일 마감가:
$26.73
열려 있는:
$26.46
하루 거래량:
205.00K
Relative Volume:
0.17
시가총액:
$1.68B
수익:
$5.79M
순이익/손실:
$-199.61M
주가수익비율:
-8.3821
EPS:
-3.01
순현금흐름:
$-188.48M
1주 성능:
-8.06%
1개월 성능:
-4.71%
6개월 성능:
+21.81%
1년 성능:
-2.00%
1일 변동 폭
$25.14
$26.80
1주일 범위
$25.14
$27.65
52주 변동 폭
$14.40
$29.05
Celldex Therapeutics Inc Stock (CLDX) Company Profile
명칭
Celldex Therapeutics Inc
전화
908-200-7500
주소
53 FRONTAGE ROAD, HAMPTON
CLDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLDX
Celldex Therapeutics Inc
|
25.23 | 1.78B | 5.79M | -199.61M | -188.48M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.97 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.67 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.67 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.64 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.94 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-10-13 | 개시 | Barclays | Underweight |
| 2025-04-28 | 개시 | Canaccord Genuity | Buy |
| 2025-03-20 | 개시 | Morgan Stanley | Overweight |
| 2025-02-13 | 개시 | UBS | Buy |
| 2024-10-07 | 개시 | Citigroup | Buy |
| 2024-09-30 | 개시 | Goldman | Neutral |
| 2024-09-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-18 | 개시 | Stifel | Buy |
| 2024-06-11 | 개시 | Wolfe Research | Outperform |
| 2023-12-20 | 개시 | TD Cowen | Outperform |
| 2023-11-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-08-22 | 개시 | Wells Fargo | Underweight |
| 2021-09-17 | 개시 | Jefferies | Buy |
| 2021-09-10 | 개시 | SVB Leerink | Outperform |
| 2021-07-22 | 개시 | Guggenheim | Buy |
| 2020-02-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-08-01 | 재개 | H.C. Wainwright | Buy |
| 2016-11-07 | 개시 | Aegis Capital | Buy |
| 2016-03-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-03-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2016-03-07 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
| 2016-03-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-03-01 | 개시 | H.C. Wainwright | Buy |
| 2015-08-11 | 재확인 | Brean Capital | Buy |
| 2015-08-11 | 재확인 | Oppenheimer | Outperform |
| 2015-08-11 | 재확인 | ROTH Capital | Buy |
| 2015-06-02 | 재확인 | WBB Securities | Strong Buy |
| 2014-11-17 | 재확인 | ROTH Capital | Buy |
| 2014-03-04 | 재확인 | Oppenheimer | Outperform |
| 2013-07-08 | 재확인 | Cantor Fitzgerald | Buy |
| 2013-03-08 | 재확인 | Cantor Fitzgerald | Buy |
| 2013-02-26 | 재확인 | Oppenheimer | Outperform |
| 2013-01-10 | 재확인 | Cantor Fitzgerald | Buy |
| 2012-10-02 | 재확인 | Oppenheimer | Outperform |
| 2012-09-14 | 재확인 | Cantor Fitzgerald | Buy |
모두보기
Celldex Therapeutics Inc 주식(CLDX)의 최신 뉴스
Why Celldex Therapeutics Inc. stock could be next big winnerMarket Sentiment Summary & Consistent Growth Equity Picks - newser.com
Why Celldex Therapeutics Inc. stock could benefit from AI revolutionEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Using data filters to optimize entry into Celldex Therapeutics Inc.July 2025 Market Mood & Advanced Technical Analysis Signals - newser.com
Real time social sentiment graph for Celldex Therapeutics Inc.2025 Key Highlights & Weekly High Return Opportunities - newser.com
Will Celldex Therapeutics Inc. (TCE2) stock outperform energy sector in 2025Quarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Is Celldex Therapeutics Inc. stock reversal real or fakeJuly 2025 Fed Impact & AI Powered Market Entry Strategies - newser.com
What MACD and RSI say about Celldex Therapeutics Inc.Earnings Beat & High Conviction Buy Zone Picks - newser.com
Published on: 2025-11-03 00:38:35 - newser.com
Signal strength of Celldex Therapeutics Inc. stock in tech scannersJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
Reversal indicators forming on Celldex Therapeutics Inc. stockMarket Trend Report & Capital Protection Trade Alerts - newser.com
What’s next for Celldex Therapeutics Inc. stock priceQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
Identifying reversal signals in Celldex Therapeutics Inc.Portfolio Value Report & Long-Term Investment Growth Plans - newser.com
How to use a screener to detect Celldex Therapeutics Inc. breakoutsJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
Positive Early CDX-622 Data Might Change The Case For Investing In Celldex Therapeutics (CLDX) - Sahm
Is Celldex Therapeutics Inc. stock a bargain at current levelsWeekly Trade Review & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-11-01 01:47:02 - newser.com
Chart overlay techniques for tracking Celldex Therapeutics Inc.Quarterly Trade Report & Precise Buy Zone Tips - newser.com
Real time alert setup for Celldex Therapeutics Inc. performanceJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Will Celldex Therapeutics Inc. stock benefit from upcoming earnings reportsPrice Action & Reliable Price Breakout Signals - newser.com
How Celldex Therapeutics Inc. (TCE2) stock trades in high volatility2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
Can Celldex Therapeutics Inc. stock reach $100 price targetQuarterly Trade Summary & Community Consensus Trade Signals - newser.com
Why analysts remain bullish on Celldex Therapeutics Inc. stockExit Point & Consistent Return Investment Signals - newser.com
What momentum shifts mean for Celldex Therapeutics Inc.July 2025 Drop Watch & Intraday High Probability Alerts - newser.com
Is it too late to sell Celldex Therapeutics Inc.2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Celldex reports positive data for CDX-622 in phase 1 study - Investing.com Canada
Celldex Announces Initial Positive Results from Phase 1 Trial of CDX-622 Demonstrating Favorable Safety and PK Profile and Sustained Mast Cell Inhibition - The Manila Times
Celldex Announces Initial Positive Results from Phase 1 - GlobeNewswire
Celldex Therapeutics (CLDX) to Release Quarterly Earnings on Wednesday - MarketBeat
Published on: 2025-10-30 03:01:01 - newser.com
Celldex Therapeutics Inc (CLDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
0.96%
자본화:
|
볼륨(24시간):